أفضل فحص شامل للغدة الدرقية التشخيص في تركيا - توب -25 أطباء

مساعد. البروفيسور نوري ألبر شهباز طبيب ذو خبرة حاصل على تعليم طبي من جامعة اسطنبول ، كلية الطب جراح باشا ، وخبرة علمية وسريرية من كلية بايلور للطب وكلية الطب بجامعة تكساس. وهو متخصص في جراحة الغدد الصماء (أورام الغدة الدرقية ، والغدة الجار درقية ، والغدة الكظرية ، وأورام الغدد الصم العصبية) وقد أجرى أكثر من 2000 عملية جراحية ناجحة في هذا المجال. كما أنه متخصص في جراحات المناظير والجراحات طفيفة التوغل ، وكذلك في تنظير الجهاز الهضمي التشخيصي والعلاجي.

ولد عام 1981 في إرزينجان. بعد الانتهاء من مدرسة بشيكتاش أتاتورك الأناضول الثانوية في عام 1999 التحق بجامعة إسطنبول تشابا، كلية الطب.

في عام 2005 حصلت على درجة الماجستير وبدأت العمل كممارس في مستشفى يوكسكوفا الحكومي. وحصلت على درجة الدكتوراه في مستشفى أوكميداني للتدريب والبحث في قسم الجراحة العامة. وبصفتي أخصائي جراحة عامة، عملت في مستشفى زونجولداك أتاتورك الحكومي لمدة 5 سنوات وفي مستشفى سانجاكتيبي شهيد البروفيسور دكتور إلهان فارانك للتدريب والبحث لمدة 3 سنوات.

عمل كأستاذ مساعد في جامعة إسطنبول ميديبول، قسم الجراحة العامة. يعمل حاليًا في مستشفى جامعة ميديبول بنديك.

تعليم:

2021 جامعة أولوداغ، أمراض الأذن والأنف والحنجرة

2014 جامعة إيجى، كلية الطب

خبرة:

2023 - 2023 جامعة العلوم الصحية مستشفى السلطان عبد الحميد خان للتدريب والأبحاث

2021 - 2022 البروفيسور الدكتور شهيت. مستشفى إيلهان فارانك سانجاكتيبي للتدريب والأبحاث

تعليم:

• الدرجة العلمية: كلية الطب، جامعة تراكيا، 2009
• التخصص الطبي: الطب الباطني، مستشفى الدكتور سادي كونوك للتدريب والأبحاث في باكيركوي، 2010-2014
• طبيب متخصص: الطب الباطني، مستشفى السلطان سليمان القانوني للتدريب والبحث، 2014-2019
• طبيب متخصص: الطب الباطني، عيادة الطب الباطني بالمستشفى التركي، قطر، 2019-2020
• طبيب متخصص: الطب الباطني، قسم الطب الباطني في مستشفى جامعة إسطنبول ميديبول، 2020-2024
• أستاذ مشارك دكتور: الطب الباطني، مستشفى ميديبول أجيباديم الإقليمي بجامعة إسطنبول ميديبول، 2024 حتى الوقت الحاضر.

الأدوار في المشاريع:

باحث فرعي (باحث مساعد) في دراسة SOUL: بحث نتائج القلب والأوعية الدموية للسيماجلوتيد في مرضى السكري من النوع 2، والتي وافقت عليها وكالة الأدوية والأجهزة الطبية التركية في 22 مايو 2019.

باحث فرعي (باحث مساعد) في الدراسة الدولية "الأنسولين SCALE™": فعالية وأمان ليراجلوتيد 3.0 مجم في المرضى الذين يعانون من زيادة الوزن أو السمنة المصابين بداء السكري من النوع 2 المعالجين بالأنسولين القاعدي (رمز الدراسة: NN8022-4272)، التي أجرتها شركة نوفو نورديسك.

باحث مساعد في الدراسة الدولية NN5401-4266 StepByStep Intensification التي أجرتها شركة نوفو نورديسك.

باحث مساعد في الدراسة "دراسة بحثية لمقارنة السيماجلوتيد بالأنسولين الأسبارت، عند تناوله مع الميتفورمين والأنسولين جلارجين، في الأشخاص المصابين بداء السكري من النوع 2 (SUSTAIN 11)" (2019-2020).

باحث مساعد في دراسة PIONEER 1: تجربة سريرية عشوائية لفعالية وأمان العلاج الأحادي بالسيماجلوتيد عن طريق الفم بالمقارنة مع الدواء الوهمي في المرضى المصابين بداء السكري من النوع 2.

التعليم والخبرة

• 1992 - 1998 جامعة غازي عنتاب كلية الطب
• 2002 – 2015 جامعة الجمهورية، كلية الطب، قسم الطب الباطني
• 2015 – 2024، مستشفى جامعة باغجلار ميديبول ميجا
• 2024 – حتى الآن، مستشفى ميديبول أجيبادم

خبرة

عيادة الأشعة بمستشفى ليمان

المركز الطبي الأكاديمي

مركز اناكلينيك الطبي

مستشفى ولاية قيصري

عيادة الأشعة بجامعة قيصري إرجييس

مركز سامسون الطبي الخاص ميديليف

مستشفى سامسون بويوك الأناضول (2023)

اوزمانليك

دكتور تولاي أوما، أستاذ مشارك

التخصص: الغدد الصماء والأمراض الأيضية

الخلفية الأكاديمية

• التعليم الطبي: جامعة إينونو، كلية الطب (البرنامج الإنجليزي)، 1994-2001.
• التدريب في الطب الباطني: مستشفى هاسكي للتدريب والبحث، 2004-2010.
• التخصص الفرعي في الغدد الصماء والتمثيل الغذائي: مستشفى أنقرة للتدريب والبحث، 2013-2017.

الخبرة المهنية

• الخبرة السريرية:
  • طبيب عام ذو مسؤوليات إدارية، 2002-2004.
  • أخصائي الطب الباطني أثناء الخدمة الإلزامية 2010-2013.
  • أخصائي الغدد الصماء وأمراض التمثيل الغذائي في مستشفى أنقرة للتدريب والبحث (2017-2023).
  • حصلت على لقب أستاذ مشارك في عام 2023، مما يعكس تميزها الأكاديمي والسريري.
    مجموعة لقمان حكيم الصحية 2023 (حتى الآن)

المساهمات والمنشورات العلمية

• مخرجات البحث:
  • تم نشر أكثر من 20 مقالاً في مجلات دولية محكمة، مع التركيز بشكل كبير على مرض السكري، واضطرابات الغدة الدرقية، ومتلازمة تكيس المبايض.
  • ألقى العديد من العروض الشفوية والملصقات في المؤتمرات الوطنية والدولية.
• مقاييس الاستشهاد:
  • مجموع الاستشهادات: 166
  • مؤشر هيرش: 6
  • مؤشر i10: 4

الجوائز والتقديرات

• حاز على العديد من الجوائز المرموقة، بما في ذلك:
  • جائزة أفضل عرض شفوي (2023): لأبحاثه الرائدة حول لقاحات كوفيد-19 ومرض جريفز.
  • جائزة أفضل ملصق (2021): للحصول على رؤى سريرية حول قصور الغدة جار الدرقية في تركيا (دراسة HiPOPARATURK-NET).

العضويات والشهادات المهنية

• عضو فعال في المنظمات الرائدة:
  • الجمعية الأوروبية للغدد الصماء (ESE) ولجنة علماء الغدد الصماء الشباب (EYES).
  • الجمعية التركية للغدد الصماء والتمثيل الغذائي.
• أكمل العديد من برامج التدريب المتقدمة، بما في ذلك الشهادات في التجارب السريرية والإحصاء الحيوي وتصوير الغدة الدرقية بالموجات فوق الصوتية.

التركيز السريري والبحثي

خبرة الدكتورة أوما تمتد إلى:

• إدارة مرض السكري ومضاعفاته.
• التشخيص المتقدم لأمراض الغدة الدرقية وعلاجها.
• متلازمة تكيس المبايض (PCOS) وتأثيراتها الأيضية.
• التحقيق في العلاقة بين النظام الغذائي والاضطرابات الغدد الصماء / الأيضية.

خبرة

• 2016 - 2017

كلية الطب بجامعة استينيا

• 2016 - 2017

مستشفى ليف

• 2016 - 2017

مستشفى ليف اولوس

• 2015 - 2016

مستشفى أجيبادم بودروم

• 2014 - 2015

مستشفى تاتفان الحكومي

• 2013 - 2015

مستشفى تاتفان الحكومي

• 2012 - 2013

عيادة كليفلاند

• 2007 - 2014

كلية الطب بجامعة دوكوز إيلول

تعليم

• 2013

جامعة دوكوز ايلول كلية الطب، كلية الطب/قسم العلوم الطبية الجراحية/قسم الجراحة العامة

• 2013

جامعة دوكوز إيلول، الجراحة العامة

• 2007

جامعة أكدنيز، كلية الطب

• 2007

المقالات المنشورة في مجلات دولية محكمة:

العنوان: تأثير فقدان العضلات على معدل الإصابة والبقاء على قيد الحياة على المدى الطويل بين المرضى الذين يعانون من نقائل الصفاق من أصل القولون والمستقيم الذين عولجوا بالجراحة التصغيرية والعلاج الكيميائي داخل الصفاق بارتفاع الحرارة: تحليل طولي لمدة 10 سنوات لتجربة مركز واحد.

• المؤلفون: أغالار جيهان، سوكمان سلمان، أرسلان أوزشاهين ناسي جيدم، ألتاي كانان، باشارا أكين إيشيل، كاندا أراس أمري، أوبوز فوندا
• المجلة: تقنيات في طب القولون والمستقيم
• السنة: 2020
• المجلد: 24(4)
• الصفحات: 301-308
• دوى: 10.1007/s10151-020-02159-z
• رقم النشر: 6776368

العنوان: تجربة عشوائية محكومة لمدة 8 أسابيع مقابل 12 أسبوعًا بين العلاج الكيميائي والإشعاعي المساعد والجراحة لسرطان المستقيم المتقدم محليًا.

• المؤلفون: ترزي جيم، بنغول مصطفى، أرسلان ناسي جيديم، أوزتورك إرسين، كاندا أراس إمري، إيشيك أوزغن، يلمازلار أحمد تونكاي، أوبوز فوندا، غوركين بيركاي، كورت ميرال، أونلو شادي ميهتات، أوراش نسرين، قناة أوزكان، أوزتوب إيلهان
• المجلة: أمراض القولون والمستقيم
• السنة: 2020
• المجلد: 22(3)
• الصفحات: 279-288
• DOI: 10.1111/codi.14867
• رقم النشر: 6012919

العنوان: تأثير غراء الفيبرين في منع تسرب خط الدبابيس بعد عملية تكميم المعدة: دراسة تجريبية على الفئران.

• المؤلفون: أوزدنكايا يسار، أولموشاجليك أوكتاي، باسم بيلين، ساكا بورجو، أرسلان ناسيي تشيدم
• المجلة: اكتا سيرورجيكا برازيليرا
• السنة: 2019
• المجلد: 34(8)
• رقم النشر: 5242669

العنوان: علاج سرطان الصفاق المكتشف أثناء الجراحة من أصل القولون والمستقيم باستخدام الجراحة التصغيرية والعلاج الكيميائي داخل الصفاق.

• المؤلفون: كاندا أراس إمري، أرسلان ناسي جيديم، ترزي جيم، سوكمان سلمان، يافوزن توبا، أوزكارديسلر سيفدا، أونلو مهتات، أوبوز فوندا، فوزون محمد.
• المجلة: المجلة العالمية لجراحة الأورام
• السنة: 2018
• المجلد: 16(1)
• الصفحات: 70-74
• دوى: 10.1186/s12957-018-1369-7
• رقم النشر: 4863133

العنوان: يمكن لقياس الحوض باستخدام الرنين المغناطيسي وقياس حجم الورم التنبؤ بصعوبة الجراحة والنتيجة الأورامية في سرطان المستقيم المتقدم محليًا من الدرجة المتوسطة إلى المنخفضة.

• المؤلفون: أتاسوي جولسن، أرسلان ناسي جيديم، إليبول فوندا، ساهول أوزغول، أوبوز فوندا، سوكمين سلمان
• المجلة: الجراحة اليوم
• السنة: 2018
• المجلد: 48(12)
• الصفحات: 1040-1051
• دوى: 10.1007/s00595-018-1690-3
• رقم النشر: 4863005

العنوان: هل التقدم في السن سبب للتردد في إجراء الجراحة التصغيرية والعلاج الكيميائي الحراري داخل الصفاق في سرطان القولون والمستقيم؟

• المؤلفون: ترزي جيم، سوكمان سلمان، أرسلان ناسي جيديم، أوزكارديسلر سيفدا، دورال جميل، أوبوز فوندا، كاندا أراس إمري، غوكترك أوميت كيليشتن
• المجلة: المجلة الدولية للجراحة
• السنة: 2018
• المجلد: 51
• الصفحات: 156-160
• دوى: 10.1016/j.ijsu.2018.01.010
• رقم النشر: 4855751

المساهمات في المؤتمرات:

العنوان: نتائج جراحة تصغير الخلايا والعلاج الكيميائي الحراري داخل الصفاق لعلاج سرطان القولون والمستقيم: تجربة في مركز واحد.

• المؤلفون: كاندا أراس أمري، سوكمان سلمان، ترزي جيم، أرسلان ناسي جيديم، أوبوز فوندا
• المؤتمر: مؤتمر الجمعية الأوروبية لجراحة الأورام (ESSO)
• السنة: 2018
• الموقع: بودابست، المجر

العنوان: العوامل التنبؤية للتحويل إلى الجراحة المفتوحة في جراحة القولون والمستقيم بالمنظار.

• المؤلفون: أرسلان ناسي جيديم، ترزي جيم، سوكمان سلمان، كاندا أراس إمري، أوبوز فوندا
• المؤتمر: مؤتمر الجمعية الأوروبية للجراحة بالمنظار (EAES)
• السنة: 2017
• الموقع: فرانكفورت، ألمانيا

PROFESSIONAL EXPERIENCE

2011-2012
Erzurum Koprukoyu State Hospital
Department: General Medicine

2012-2017
Istanbul University Cerrahpaşa Medical Faculty
Department: Internal Medicine

06/2017-10/2017
Istanbul Gaziosmanpasa Taksim Training and Research Hospital
Department: Internal Medicine

10/2017-11/2018
Istanbul University Istanbul Medical Faculty
Department: Allergy and Immunology Fellowship

2018/2022
Istanbul University Oncology Institute
Department: Medical Oncology Fellowship

2022-2023
Tekirdag City Hospital
Department: Medical Oncology Specialist

2023-present
Istanbul Medipol University Medipol Bahcelievler Private Hospital
Department: Medical Oncology Assoc. Prof.

EDUCATION

2005-2011
Medical Education
Sivas Cumhuriyet University Medical Faculty, Sivas, Turkey

2012-2017
Internal Medicine
Istanbul University Cerrahpaşa Medical Faculty, Department of Internal Medicine, Istanbul, Turkey

2017-2018
Allergy-Immunology Fellowship
Istanbul University Istanbul Medical Faculty
Department of Internal Medicine, Division of Allergy and Immunology, Istanbul, Turkey

2018-2022
Medical Oncology Fellowship
Istanbul University Oncology Institute, Department of Medical Oncology, Istanbul, Turkey

2022
ESMO Board Certification in Medical Oncology
10th September 2022 in Paris, France.

2023
Medical Oncology Assoc. Prof.
Istanbul Medipol University Department of Medical Oncology, Istanbul, Turkey

INTERNATIONAL CLINICAL TRIALS:

1. Astefania - ROCHE

• Title: A Study Evaluating the Efficacy and Safety of Adjuvant Atezolizumab or Placebo and Trastuzumab Emtansine for Participants With HER2-Positive Breast Cancer at High Risk of Recurrence Following Preoperative Therapy
• Role: Subinvestigator

2. PFİZER

• Title: A Study Of Lorlatinib Versus Crizotinib In First-Line Treatment Of Patients With ALK-Positive NSCLC
• Role: Subinvestigator

3. RECITE - AMGEN

• Title: Study of Romiplostim for Chemotherapy-induced Thrombocytopenia in Adult Subjects With Gastrointestinal, Pancreatic, or Colorectal Cancer
• Role: Subinvestigator

4. NAVIGATE - BAYER

• Title: A Study to Test the Effect of the Drug Larotrectinib in Adults and Children With NTRK-fusion Positive Solid Tumors
• Role: Subinvestigator

5. RUBY - Tesaro (PRA)

• Title: A Phase 3, Randomized, Double-blind, Multicenter Study of Dostarlimab (TSR-042) Plus Carboplatin-paclitaxel Versus Placebo Plus Carboplatin-paclitaxel in Patients With Recurrent or Primary Advanced Endometrial Cancer
• Role: Subinvestigator

6. ENGOT-ov43/GOG-3036 - MSD

• Title: Study of Chemotherapy With Pembrolizumab (MK-3475) Followed by Maintenance With Olaparib (MK-7339) for the First-Line Treatment of Women With BRCA Non-mutated Advanced Epithelial Ovarian Cancer (EOC) (MK-7339-001/KEYLYNK001/ENGOT-ov43/GOG-3036)
• Role: Subinvestigator

7. ASTRA ZENECA

• Title: To Study Clinical Effectiveness and Safety of Olaparib Monotherapy in Metastatic Breast Cancer Patients.
• Role: Subinvestigator

8. ROSY-O - ASTRA ZENECA

• Title: Roll Over StudY for Patients Who Have Completed a Previous Oncology Study With Olaparib
• Role: Subinvestigator
•  

INTERNATIONAL PUBLICATIONS

I. Published journal articles indexed by SCI, SSCI, and AHCI

Weekly Paclitaxel in Classic Kaposi Sarcoma

• Authors: Paksoy, N., Khanmammadov, N., Doğan, İ., Ferhatoğlu, F., Ahmed, M. A., Karaman, S., & Aydiner, A.
• Journal: Medicine, 102(5)

Carboplatin Desensitization in Ovarian Carcinoma

• Authors: Paksoy, N., Khanmammadov, N., Doğan, İ., Ferhatoğlu, F., Yildiz, A., Ak, N., & Aydiner, A.
• Journal: Medicine, 101(45), e31726

High-Dose Chemotherapy for Ewing’s Sarcoma

• Authors: Paksoy, N., Ferhatoglu, F., Dogan, İ., Khanmammadov, N., Celik, A. I., Gulbas, Z., & Başaran, M.
• Journal: Medicine, 101(49), e32213

Multidrug Refractory TFE3(+) Renal Cell Carcinoma

• Authors: Paksoy, Nail, et al.
• Journal: Journal of Oncology Pharmacy Practice, 2022, 28.1: 215-221

Crizotinib Efficacy in NSCLC with MET Alterations

• Authors: Gürbüz, M., Kiliçkap, S., Bilici, A., Karadurmuş, N., Sezer, A., Şendur, M. A. N., ... & Demirkazik, A.
• Journal: Medicine, 101(50), e32368

Clinicopathological Features in ALK Mutant NSCLC

• Authors: Dogan, I., Gurbuz, M., Paksoy, N., Ferhatoglu, F., Vatansever, S., Saip, P., ... & Aydiner, A.
• Journal: Medicine, 101(34)

PSMA-Based Tumor Burden in Prostate Cancer

• Authors: HAS SIMSEK, Duygu, et al.
• Journal: Annals of Nuclear Medicine, 2021, 35.6: 680-690

Atezolizumab in Metastatic Urothelial Carcinoma

• Authors: TURAL, Deniz, et al.
• Journal: European Urology Focus, 2021, 7.5: 1061-1066

Pulmonary Sarcomatoid Carcinoma

• Authors: FERHATOGLU, Ferhat, et al.
• Journal: Oncology Research and Treatment, 2021, 44.11: 590-601

Prognostic Factors in Atezolizumab-Treated Urothelial Carcinoma

• Authors: TURAL, Deniz, et al.
• Journal: International Journal of Clinical Oncology, 2021, 26.8: 1506-1513

Atezolizumab with Chemotherapy in Small Cell Lung Cancer

• Authors: GÜRBÜZ, Mustafa, et al.
• Journal: Journal of Cancer Research and Clinical Oncology, 2022, 1-9

FOLFIRINOX vs. Gemcitabine + Nab-Paclitaxel in Pancreatic Cancer

• Authors: AY, Seval, et al.
• Journal: Journal of Chemotherapy, 2022, 1-7

Trastuzumab Emtansine in Older HER2-Positive Breast Cancer Patients

• Authors: CIL, Ibrahim, et al.
• Journal: Tumori Journal, 2022, 108.1: 19-25

Real-Life Efficacy of Osimertinib in Advanced NSCLC

• Authors: HIZAL, Mutlu, et al.
• Journal: Journal of Cancer Research and Clinical Oncology, 2022, 148.6: 1501-1508

ALK-Positive Cells Percentage and Alectinib Efficacy

• Authors: Hizal, M., Bilgin, B., Paksoy, N., Atcı, M. M., Kahraman, S., Kılıçkap, S., ... & Şendur, M. A. N.
• Journal: Journal of Cancer Research and Clinical Oncology, 149(8), 4141-4148

Real-World Data on Alectinib in ALK-Positive NSCLC

• Authors: Hizal, M., Bilgin, B., Paksoy, N., Kılıçkap, S., Atcı, M. M., Kahraman, S., ... & Şendur, M. A. N.
• Journal: Future Oncology, 18(23), 2573-2582

Prognostic Factors in Metastatic RCC with T790M Mutation

• Authors: Dogan, I., Iribas, A., Paksoy, N., Vatansever, S., & Basaran, M.
• Journal: Journal of Cancer Research and Therapeutics

FLOT Regimen in Metastatic Gastric Cancer

• Authors: Tastekin, D., Paksoy, N., Dogan, I., Ferhatoglu, F., Khanmammadov, N., Bozbey, H. U., & Karabulut, S.
• Journal: Journal of Cancer Research and Therapeutics

Desensitization Protocol in Lenalidomide Hypersensitivity Reactions

• Authors: DEMIR, Semra, et al.
• Journal: Annals of Allergy, Asthma & Immunology, 2019, 123.4: 394-397

Factors Associated with Diagnostic Skin Test Positivity in PPI Hypersensitivity

• Authors: ÖZDEMIR, Seçil Kepil, et al.
• Journal: Allergy, 2019, 74.6: 1187-1190

Efficacy of Capecitabine and Temozolomide in Neuroendocrine Tumors

• Authors: Ünal, Ç., Azizy, A., Karabulut, S., Taştekin, D., Akyıldız, A., Yaşar, S., ... & Sağlam, S.
• Journal: The Oncologist, oyad257

Subsequent Treatments in Hormone-Positive Breast Cancer Progression

• Authors: Karacin, C., Oksuzoglu, B., Demirci, A., Keskinkılıç, M., Baytemür, N. K., Yılmaz, F., ... & Hacıbekiroğlu, İ.
• Journal: BMC cancer, 23(1), 192

Termination of Trastuzumab in HER2-Positive Metastatic Breast Cancer

• Authors: Dogan, I., Aydin, E., Khanmammadov, N., Paksoy, N., Saip, P., & Aydiner, A.
• Journal: Scientific Reports, 13(1), 8779

Long-term Outcomes and Predictors of Recurrence in Node-Negative Early Stage Breast Cancer

• Authors: Dogan, I., Aydin, E., Khanmammadov, N., Paksoy, N., Ferhatoğlu, F., Ak, N., ... & Aydiner, A.
• Journal: Journal of Cancer Research and Clinical Oncology, 1-9

Prognostic Factors Influencing PFS in HER2-Positive Metastatic Breast Cancer

• Authors: Doğan, İ., Paksoy, N., Ak, N., Vatansever, S., Saip, P., & Aydıner, A.
• Journal: European Journal of Breast Health, 19(2), 128

Treatment Efficacy of Ribociclib or Palbociclib plus Letrozole in Metastatic Breast Cancer

• Authors: Kahraman, S., Erul, E., Seyyar, M., Gumusay, O., Bayram, E., Demirel, B. C., ... & Nahit Sendur, M. A.
• Journal: Future Oncology, 19(10), 727-736

Efficacy and Safety of Sorafenib in Adult Metastatic Osteosarcoma Patients

• Authors: Dogan, I., Paksoy, N., & Basaran, M.
• Journal: Journal of Cancer Research and Therapeutics

Single-Agent Temozolomide as Salvage Therapy in Heavily Pretreated Metastatic Sarcoma Patients

• Authors: Dogan, I., Paksoy, N., & Basaran, M.
• Journal: Journal of Cancer Research and Therapeutics

Outcomes and Prognostic Factors in Metastatic Renal Cell Carcinoma with Brain Metastases

• Authors: Dogan, I., Iribas, A., Paksoy, N., Vatansever, S., & Basaran, M.
• Journal: Journal of Cancer Research and Therapeutics

FLOT Regimen in First-Line Treatment of Metastatic Gastric Cancer

• Authors: Tastekin, D., Paksoy, N., Dogan, I., Ferhatoglu, F., Khanmammadov, N., Bozbey, H. U., & Karabulut, S.
• Journal: Journal of Cancer Research and Therapeutics

Prognostic Factors of Perioperative FLOT Regimen in Operable Gastric Cancer

• Authors: Erol, C., Sakin, A., Basoglu, T., Ozden, E., Cabuk, D., Dogan, M., ... & Sendur, M. A. N.
• Journal: [Not specified]

Efficacy and Outcomes of Systemic Chemotherapy in Posttransplant Kaposi Sarcoma

• Authors: Khanmammadov, N., Paksoy, N., Doğan, I., Ferhatoğlu, F., Saip, P., & Aydiner, A.
• Journal: Medicine, 102(39), e35383

Comparison of Second-Line Treatments in Metastatic Renal Cell Carcinoma

• Authors: Pehlivan, M., Paksoy, N., Aydin, E., Basaran, M., & Ekenel, M.
• Journal: Medicine, 102(41), e35245

Toxicity Management and Effectiveness of Regorafenib in Advance GIST Patients: A Real-world Study - Authors: Paksoy, N., Ferhatoğlu, F., Doğan, İ., Khanmammadov, N., Bozbey, H. U., Karabulut, S., & Taştekin, D. - Journal: TURKISH JOURNAL OF ONCOLOGY, 1(1)

Demographic and Clinical Features and Factors Associated with Survival in Patients with Primary Glomerulonephritis: Single Tertiary Center Experience - Authors: Paksoy, N., Trabulus, S., Seyahi, N., & Altiparmak, M. R. - Journal: Namik Kemal Tip Dergisi, 11(1)

Efficacy of Sorafenib in Symptomatic Patients with Pretreated Progressive Desmoid Tumors - Authors: Paksoy, N., Ferhatoglu, F., Dogan, I., Ak, N., Pehlivan, M., Ekenel, M., & Basaran, M.

Nodal Response to Neoadjuvant Chemotherapy is a Better Predictive Factor of Survival Than Miller-Payne Scoring in Breast Cancer - Authors: Ak, Naziye, et al. - Journal: Journal of Oncological Sciences, 7.2: 42-49

Evaluation of Prognostic and Predictive Values of Hemogram Parameters in Patients with Advanced Stage Ovarian Carcinoma - Authors: Ak, Naziye, et al. - Journal: Turkish Journal of Oncology/Türk Onkoloji Dergisi, 2021, 36.4

Identifying Risk Factors Associated with Survival and Drug-Related Toxicities in Imatinib-Resistant Gastrointestinal Stromal Tumor (GIST) Patients Treated with Sunitinib - Authors: Ferhatoglu, F., Karabulut, S., Paksoy, N., & Tastekin, D.

Real-life Outcomes of ROS1 Fusion-positive Metastatic Lung Cancer Patients who were Treated with Crizotinib - Authors: Dogan, İ., Khanmammadov, N., Paksoy, N., Ferhatoglu, F., Aydın, E., Vatansever, S., & Aydine, A. - Journal: TURK ONKOLOJI DERGISI-TURKISH JOURNAL OF ONCOLOGY

Predictors of the acquisition of T790M mutation in EGFR-mutant metastatic lung cancer patients who were treated with EGFR inhibitors - Authors: Dogan, I., Khanmammadov, N., Paksoy, N., Vatansever, S., Saip, P., & Aydıner, A. - Journal: Eurasian Journal of Pulmonology

Laterality of Adrenal Gland Metastasis in Lung Cancer: Results of a Comparative Study - Authors: Ferhatoglu, F., Gagatay, T., Okumus, G., Aydiner, A., Paksoy, N., Ak, N., ... & Saip, P. - Journal: Eurasian Journal of Medical Investigation, 7(2)

Poor Risk Factors Affecting Cancer Patients Infected with Covid-19: A Retrospective Comparative Study from a Pandemic Hospital - Authors: Ferhatoglu, F., Kapağan, T., Paksoy, N., Ak, N., Medetalibeyoğlu, A., Şenkal, N., ... & Vatansever, S. - Journal: Turk Onkoloji Dergisi, 38(1)

Systemic Treatment Outcomes of Progressive Medullary Thyroid Carcinoma from the Registries of a Tertiary Cancer Center - Authors: Ferhatoglu, F., Paksoy, N., & Başaran, M. - Journal: Namik Kemal Tip Dergisi, 10(4)

Evaluation of clinical features and risk factors related to late recurrence (> 5 years) in patients with breast cancer - Authors: Ferhatoglu, F., Aydiner, A., & Paksoy, N. - Journal: Journal of Surgery & Medicine (JOSAM), 6(12)

Assessing the Clinical Impact of Lutetium-177 DOTATATE Peptide Receptor Radionuclide Therapy (PRRT) on Metastatic Neuroendocrine Tumors: A Multicenter Real-World Data from Türkiye

Thesis:

Istanbul University Cerrahpaşa Medical Faculty, Internal Medicine Department PAKSOY, Nail. Demographical, clinical characteristics and survival factors in patients withprimary glomerulonephritis: Cerrahpasa Medical Faculty Experience. (2016)

International Refereed Congress / Symposium Publications in Proceedings (ASCO/ESMO Abstracts)

Prognostic factors influencing progression-free survival in HER2 positive metastatic breast cancer patients who treated with lapatinib and capecitabine combination

• Authors: Dogan, I., Paksoy, N., Ak, N., Vatansever, S., Saip, P., & Aydiner, A. (2022)

Efficacy of regorafenib and 5-fluorouracil-based rechallenge treatment in the third-line treatment of metastatic colorectal cancer: A Turkish oncology group study

• Authors: Şenocak Taşçi, E., Oyan, B., Sonmez, O., Mutlu, A. U., Atcı, M. M., Oner, I., ... & Gulmez, A. (2022)

Long-term outcomes and predictors of recurrence in patients with early-stage node-negative breast cancer

• Authors: Dogan, I., Aydin, E., Paksoy, N., Ferhatoglu, F., Ak, N., Ibis, K., ... & Aydiner, A. (2021)

Efficacy of temozolomide in pretreated patients with metastatic sarcoma

• Authors: Paksoy, N., Dogan, I., Ekenel, M., & Basaran, M. (2021)

Efficacy of sorafenib in symptomatic patients with pretreated progressive desmoid tumors

• Authors: Ferhatoglu, F., Paksoy, N., Dogan, I., Ak, N., Pehlivan, M., Ekenel, M., & Basaran, M. (2021)

Efficacy of sorafenib in heavily pretreated adult patients with metastatic osteosarcoma

• Authors: Paksoy, N., Dogan, I., Ekenel, M., & Basaran, M. (2021)

Outcomes and prognostic factors in metastatic renal cell carcinoma patients with brain metastases

• Authors: Dogan, İ., Iribas, A., Paksoy, N., Ekenel, M., Vatansever, S., & Basaran, M. (2021)

Association of response to first-line chemotherapy with the efficacy of atezolizumab in patients with metastatic urothelial carcinoma

• Authors: Tural, D., Olmez, O. F., Sümbül, A. T., Artac, M., Ozhan, N., Akar, E., ... & Erman, M. (2021)

Safety and survival in adult women with platinum-sensitive relapsed BRCA mutant ovarian cancer: A study of patients in Olaparib Turkey Early Access Program—LynTurk study

• Authors: Esin, E., Ahmed, M. A., Yıldırım, H. Ç., Mandel, N. M., Erdemoglu, E., Sari, M., ... & Paydas, S. (2023)

Atezolizumab in patients with metastatic urothelial carcinoma who have progressed after first-line chemotherapy: Results of real-life experiences

• Authors: Tural, D., Ölmez, Ö. F., Sümbül, A. T., Artaç, M., Özhan, N., Akar, E., ... & Kılıçkap, S. (2021)

Position:

Associate Professor ,

General Surgery Department

ISTANBUL MEDIPOL UNIVERSITY PENDIK HOSPITAL General Surgery Department

PERSONAL INFORMATION

Birth Date: 14.05.1982 

Place of Birth      : Şanlıurfa, Türkiye

Married, father of one.

CITIZENSHIP:

Republic of Turkey

EDUCATION:

Specialization:

General Surgery Department

Istanbul Kartal Dr. Lütfü Kırdar Training and Research Hospital (2009- 2014)

University

Istanbul University Istanbul Faculty of Medicine (20022008)

Anadolu University Faculty of Business Administration - Administration of Health Institutions (2013-2015)

Anadolu University Faculty of Open Education Department of Law (2016-)

High school

Erzincan Science High School (1998-2002)

Working Experience:

ERZINCAN NEVZAT AYAZ SCIENCE HIGH SCHOOL 1998-2002

ISTANBUL UNIVERSITY ISTANBUL FACULTY 2002-2009

GENERAL SURGERY ASSISTANT ISTANBUL KARTAL DR. LUTFI KIRDAR TRAINING AND RESEARCH HOSPITAL 2009-2014

SPECIALIST PHYSICIAN MEDENIYET UNIVERSITY GOZTEPE TRAINING AND RESEARCH HOSPITAL 2014-2015

CHIEF PHYSICIAN T.R.  MINISTRY OF HEALTH SILOPI STATE HOSPITAL 2015-2016

SPECIALIST PHYSICIAN T.R. MINISTRY OF HEALTH DERINCE TRAINING AND RESEARCH HOSPITAL, 2018-2020

SPECIALIST PHYSICIAN SANLIURFA MEHMET AKIF INAN TRAINING AND RESEARCH HOSPITAL 2016-2018

ASSOCIATE PROFESSOR ISTANBUL KARTAL DR. LUTFI KIRDAR CITY HOSPITAL 2020-2023

İSTANBUL MEDIPOL UNIVERSITY PENDIK HOSPITAL 2023-

PUBLICATIONS

National and International Articles

1 GÖK MEHMET ALİ, KAFADAR MEHMET TOLGA (2021). Inguinal hernia repair via laparoscopic transabdominal preperitoneal (TAPP) method: Our 2 years clinical results. Annals of Medical Research, 28(4), 812-815., Doi: 10.5455/annalsmedres.2020.05.443

2 SAĞIROĞLU ŞÜKRİYE JÜLİDE, ÖZDEMİR TUĞRUL, ATAK TUBA, GÖK MEHMET ALİ, ORHUN ERDOĞAN KIVILCIM, EREN TURGUT TUNÇ, ALİMOĞLU ORHAN (2016). Laparoscopic Total Extraperitoneal Inguinal Hernia Repair Without Mesh Fixation: Report of Early Outcomes. SouthernPrint Date :22/10/2022 17:41:41 Clinics of Istanbul Eurasia, 27(3), 215-219., Doi: 10.14744/scie.2017.64872 

3 ÇİFTÇİ ALİ, GÖK MEHMET ALİ, KAFADAR MEHMET TOLGA (2022). Management of Acute Biliary Pancreatitis in Cholecystectomized Patients. Bezmiâlem Science, 10(4), 507-511. Doi: 10.14235/ bas galenos. 2021.6708

4 GÖK MEHMET ALİ, YEĞEN SERKAN FATİH, KAFADAR MEHMET TOLGA, KOCAOĞLU AYTAÇ EMRE (2022). Gastrointestinal Stromal Tümörlerde İmmünohistokimyasal Markırların ve Tümör Boyutunun Prognoz Üzerindeki Rolü. Kocaeli Tıp Dergisi, 10(2), 101-104. M-784-1650 KAFADAR MEHMET TOLGA, GÖK MEHMET ALİ (2022). Laparoscopic transabdominal preperitoneal repair of strangulated femoral hernia: Superiority of an unusual emergency surgical approach due to a case. Annals of Medicine and Surgery, 36(1), 110-112.

5 GÖK MEHMET ALİ, KARADAYI BÜYÜKÖZSOY AYŞEGÜL, KAFADAR MEHMET TOLGA (2022). The sensitivity of ultrasound in the clinical diagnosis of inguinal hernias in adults: a comparative study. Journal of Ultrasound, 1-4., Doi: 10.1007/s40477-021-00641-4

6 KARADAYI BÜYÜKÖZSOY AYŞEGÜL, KARATAY EMRAH, GÖK MEHMET ALİ (2022). Comparison of the Effectiveness of Ultrasound Imaging and Perioperative Measurement in the Diagnosis and Characterization of Incisional Hernia. Journal of Medical Ultrasound, 1-5.

7 GÖK MEHMET ALİ, DEMİR MUSTAFA, YEĞEN SERKAN FATİH, KAFADAR MEHMET TOLGA, ŞENOL METİN, KOCAOĞLU AYTAÇ EMRE, AKIN EMRAH (2022). Endoscopic Intra-gastric Botulinum Toxin A for Obesity Treatment: IsIt Effective?. Kocaeli Tıp Dergisi, 11(2), 149-152.

8 GÖK MEHMET ALİ, KARATAY EMRAH, ÇİFTÇİ ALİ (2022). İnguinal Hernilerde Balonsuz ve Mesh Sabitleyicisiz Laparoskopik Total Ekstraperitoneal Onarımın Cerrahi Deneyim ile Korelasyonu. Dicle Medical Journal, 49(3), 498-503., Doi: 10.5798/dicletip.1170263

9 KAFADAR MEHMET TOLGA, GÖK MEHMET ALİ (2022). Effects of Carvedilol on Liver İschemiaReperfusion İnjury in Rats. Ulusal Travma ve Acil Cerrahi Dergisi-Turkish Journal of Trauma & Emergency Surgery, 28(7), 885-893.

10 ŞENOL METİN, GÖK MEHMET ALİ (2022). Small Bowel Obstruction due to Phytobezoar. Kocaeli Tıp Dergisi, 11(2), 1-6.

11 KARATAY EMRAH, GÖK MEHMET ALİ, JAVADOV MIRKHALIG (2021). Measurement of hiatal surface area and other hiatus oesophageal diameters at computed tomography imaging in patients with gastroesophageal reflux disease and its relationship with hiatal hernia. Journal of Minimal Access Surgery, 17(4), 537-541., Doi: 10.4103/jmas.JMAS_175_20

12 GÖK MEHMET ALİ, KAFADAR MEHMET TOLGA, YEĞEN SERKAN FATİH (2021). Perforated colorectal cancers; clinical outcomes \nof 18 patients who underwent emergency surgery. Gastroenterology Review, 16(2), 161-165., Doi: 10.5114/pg.2021.106667

13 YEĞEN SERKAN FATİH, KAFADAR MEHMET TOLGA, GÖK MEHMET ALİ (2020). Comparison of Perioperative Standard and Immunomodulating Enteral Nutrition in Patients Received Major Abdominal Cancer Surgery: a Prospective, Randomized, Controlled Clinical Trial. Indian Journal of Surgery, 82, 828-834., Doi: 10.1007/s12262-020-02114-0 

14 GÖK MEHMET ALİ, KAFADAR MEHMET TOLGA, YEĞEN SERKAN FATİH (2020). Effects of Preoperative Oral Carbohydrate Loading on Preoperative and Postoperative Comfort in Patients Planned to Undergo Elective Cholecystectomy: A Prospective Randomized Controlled Clinical Trial. Iranian Red Crescent Medical Journal, 22(11), 1-6., Doi: 10.32592/ircmj.2020.22.11.107

15 GÖK MEHMET ALİ, KAFADAR MEHMET TOLGA, YEĞEN SERKAN FATİH (2019). Comparison of negative-pressure incision management system in wound dehiscence: A prospective, randomized, observational study. Journal of Medicine and Life, 12(3), 276-283., Doi: 10.25122/jml-2019-0033

16 KAFADAR MEHMET TOLGA, YALÇIN METİN, DADÜK YILDIRAY, SOYALP MURAT, GÖK MEHMET ALİ (2018). Laparoscopic Cholecystectomy for Acute Cholecystitis in Situs Inversus Totalis: An Extraordinary Approach. Eurasian Journal of Emergency Medicine, 17(2), 82-84.

17 KAFADAR MEHMET TOLGA, TEKER İBRAHİM, GÖK MEHMET ALİ, UĞURLU ESAT TAYLAN, ÇETİNKAYA ISMAİL (2018). Atraumatic splenic rupture secondary to abscess in a hemodialysis patient: a rare and fatal cause of acute abdomen diagnosed late. Journal of Surgical Case Reports,5, 1-3., Doi: 10.1093/jscr/rjy103

18 KAYA FERUDUN, KAFADAR MEHMET TOLGA, KISMET KEMAL, GÖK MEHMET ALİ, ERTAŞ ERTUĞRUL (2018). Congenital Transmesenteric Hernia Without Bowel Strangulation in a Young Adult. The Medical Bulletin Of Haseki, 56(4), 337-340., Doi: 10.4274/haseki.galenos.2022.8361

19 GÖK MEHMET ALİ, KAFADAR MEHMET TOLGA, GÜNEŞ ABDULLAH (2018). Laparoscopic treatment of hepatic hydatid disease: Şanlıurfa-Turkey experience and early clinical outcomes. Laparoscopic Endoscopic Surgical Science, 25(3), 98-102., Doi:14744/less.2018.4353171203046744-1078.03 Basım Tarihi 22/10/2022 17:41:41 Sayfa: 2

20 KAFADAR MEHMET TOLGA, YALÇIN METİN, GÖK MEHMET ALİ, AKTAŞ AYŞEGÜL, YÜREKLİ TACİTTİN SEMİH, ARSLAN AYŞEGÜL İSAL (2017). intraparenchymal Leiomyoma of the Breast: A Rare Location for an Infrequent Tumor. intraparenchymal Leiomyoma of the Breast: A Rare Location for an Infrequent Tumor, 13(3), 156-168., Doi: 10.5152/ejbh.2017.3472

 21 GÖK MEHMET ALİ, KAFADAR MEHMET TOLGA, ÖTER VOLKAN (2017). Early-term elective laparoscopic resection after endoscopic detorsion in cases with sigmoid colonic volvulus. Annals of Clinical and Analytical Medicine, 8(6), 492-495., Doi: 10.4328/JCAM.5231

22 KAFADAR MEHMET TOLGA, GÖK MEHMET ALİ, ÖTER VOLKAN (2017). Late-diagnosed penetrating stab Wounds in diaphragm and herniation. Annals of Clinical and Analytical Medicine, 8(4), 367-369., Doi: 10.4328/JCAM.5103

23 ANADOLULU ALİ İHSAN, KAFADAR MEHMET TOLGA, GÖK MEHMET ALİ, ANADOLULU ZEYNEP (2017). Laparoscopic spleen-preserving distal pancreatectomy with splenic vessel preservation for pancreatic pseudocyst in a 10-year-old boy. Journal of Pediatric Surgery Case Reports, 34(1), 10-12.

Proceedings

National and International Proceedings

İnguinal Hernilerde Total Ekstraperitoneal Onarımda Balon Disseksiyonu ile Teleskopik Disseksyonun   Kıyaslanması, KAFADAR MEHMET TOLGA, GÖK MEHMET ALİ (2022). 22.. Ulusal Cerrahi Kongresi, 

İNSİZYONEL HERNİLERDE LAPAROSKOPİK VE KONVANSİYONEL ONARIM YÖNTEMLERİ ARASINDAPOSTOPERATİF AĞRI, GÖK MEHMET ALİ, JAVADOV MIRKHALIG (2021). 8.. Ulusal Fıtık Kongresi

Laparaskopık total ekstraperıitoneal (TEP) onarımında redükte edilemeyen keseler enerji

cıihazıyla lıigate edılebırlıir mı , KAFADAR MEHMET TOLGA, GÖK MEHMET ALİ (2019). 7..

Ulusal Fıtık Kongresi

TEK İNSİZYON LAPARASKOPİK TOTAL EKSTRAPERİTONEAL İNGUİNAL HERNİ ONARIMI DENEYİMİMİZ, GÖK MEHMET ALİ, DEMİR MUSTAFA (2019). 14.. Endoskopik Laparoskopik Cerrahi Kongresi

Laparaskopik Sleeve Gastrektomide 3D Görüntüleme Sisteminin Etkiniliği , GÖK MEHMET ALİ, KAYA FERUDUN, KAFADAR MEHMET TOLGA, AKSOY BAŞAR (2017). 2.. Bariatrik ve Metabolik Cerrahi Kongresi

İnsizyonel hernide laparaskopik preperitoneal onarım, GÖK MEHMET ALİ, KAFADAR MEHMET TOLGA (2017).. 9.. Cerrahi Araştırma Kongresi

ERCP Yapılan Kist Hidatikli Hastalarda Kist Küçülür mü, YALÇIN METİN, GÖK MEHMET ALİ, KAFADAR MEHMET TOLGA (2017).. 13.. Türk Hepatopankreatobilier Cerrahi Kongresi

İnsizyonel Hernilerde TAPP Onarım Mümkün mü, GÖK MEHMET ALİ, AKSOY BAŞAR, KAFADAR MEHMET TOLGA, YALÇIN METİN (2017).. 6.. Ulusal Fıtık Kongresi, (Özet bildiri)

HİATAL HERNİLERDE LAPAROSKOPİK YAKLAŞIM, GÖK MEHMET ALİ, YALÇIN METİN, KAFADAR MEHMET TOLGA, YILMAZ TACETTİN SEMİH, AKTAŞ AYŞEGÜL (2017).. 13.. Endoskopik Laparoskopik Cerrahi Kongresi

KLİNİĞİMİZDE İNGUİNAL HERNİDE 3 TEKNİĞİN KARŞILAŞTIRLMASI, YALÇIN METİN, GÖK MEHMET ALİ, ÇEKİÇ TOLGA FARUK, KABALAK BİLAL, ÖTER VOLKAN, AKTAŞ AYŞEGÜL (2017). Ulusal Endoskopik Laparoskopik Cerrahi Kongresi

Kolon Divertikül  Perforasyonlarında Hartmann Prosedürü veya Primer Anastomoz? , GÖK MEHMET ALİ, KEŞKÜŞ BRAHIM H. HÜDAVERDI, BÖZKURT AHMET ÇAĞLAR, YALÇIN METİN, YILMAZ TACETTİN SEMİH (2017).. 11.. Ulusal Travma ve Acil Cerrahi Kongresi, (Özet bildiri)

GASTROİNTESTİNAL PREKANSEROZ LEZYONLARDA ENDOSKOPİK MUKOZAL REZEKSİYONUN ROLÜ, ORMAN SÜLEYMAN, GÖK MEHMET ALİ, EREN TURGUT TUNÇ, LEBLEBİCİ METİN, ALİMOĞLU ORHAN (2015). 12.. Ulusal Endoskopik Laparoskopik Cerrahi Kongresi

PİYES MAMAOGRAFİSİNDE KİTLE YOK! NE YAPILMALIM, ESER MEHMET, HATİPOĞLU HAYAT, GÜNDOĞAN ERSİN, GÖK MEHMET ALİ, ÇETİN KENAN, ACAR AYLİN, TAN SEDAT, BİLDİK NECDET (2014).. 19.. Ulusal Cerrahi Kongresi

LAPAROSKOPİK KOLESİSTEKTOMİ YAPILAN HASTALARDA TROKAR YERİ FITIĞI GELİŞİMİNDE ETKİLİ OLABİLECEK FAKTÖRLERİN ARAŞTIRILMASI, GÖK MEHMET ALİ, KÜNDEŞ MUHAMMED FİKRİ, KEMENT METİN, ATICI ALİ EMRE, KAPTANOĞLU LEVENT, İLHAN NOYAN, CAN UĞUR, BİLDİK NEJDET, VURAL SELAHATTİN (2014).. 19.. ULUSAL CERRAHİ KONGRESİ 

Books

Written sections in international books

1)Genel Cerrahide Nadir Görülen Acil ve Elektif Vakalar, Bölüm adı:(Akciğere Fistülize Karaciğer Kist Hidatik Vakasına Acil Laparoskopik Yaklaşım) (2020)., COŞKUN MURAT, GÖK MEHMET ALİ,

Akademisyen Yayınevi, Editör: Ender ANILIR Mehmet BAYRAK Mehmet Tolga KAFADAR Mert TANAL Ali Emre NAYCI Hüseyin KILAVUZ Özlem Öndeş BAYAR, Basım sayısı:1, Sayfa Sayısı 655, ISBN:978- 625-7275-23-1, Türkçe(Bilimsel Kitap)

2)Gastrointestinal Sistem Kanserlerinin Cerrahisi, Bölüm adı:(Karaciğerin Primer Solid MalignNeoplazileri) (2020)., GÖK MEHMET ALİ, Akademisyen Yayınevi, Editör: Hüseyin Özgür AYTAÇ, Basım sayısı:1, Sayfa Sayısı 404, ISBN:978-605-258-949-6, Türkçe (Bilimsel Kitap)

3)Gastrointestinal Sistem Tümörleri-1, Bölüm adı:(ERKEN EVRE HASTALIKTA CERRAHİ TEDAVİ) (2019)., GÖK MEHMET ALİ, Akademisyen Yayınevi, Basım sayısı:1, Sayfa Sayısı 493, ISBN:978-605-258-551-1, Türkçe (Bilimsel Kitap)

Editorship

1) Minimal İnvaziv Cerrahi, Kitap, Editör, Akademisyen Kitapevi A.Ş., 22.10.2020-15.07.2021

2. YENİ NESİLCERRAHİ, Kitap, Editör, Akademisyen Kitapevi A.Ş., 15.06.2021-15.08.2022

3. Onkolojik Cerrahi, Kitap, Editör, Akademisyen Kitapevi A.Ş., 05.04.2021-05.12.2021

4.. Fıtık Cerrahisi, Kitap, Editör, Akademisyen Kitapevi A.Ş., 07.04.2020-07.11.2020

Certificates

Hernia A to Z Fundemantals Hands on Workshop, Laparoscopic Hernia Surgery Experience Certificate in Cadaver was awarded by the European Hernia Society.

. DUBAİ/ U.A.E, 28.11.2018 

CADAVER TRAINING EVENT IN COLON AND RECTAL SURGERY, Robotic Colorectal Surgery in Cadaver training certificate was given.  STONY BROOK UNİVERSİTY / NEWYORK/ USA,.04.2016

Memberships in Scientific Organizations:

1.. Turkish Society of Colon and Rectum Surgery, Member, 2020

2.. Turkish Surgical Association, Member, 2014

Medical Interests 

Obesity 

Insulin resistance 

Diabetes 

Hypoglycemia (low sugar) 

Growth retardation and short stature 

Anorexia 

growth hormone deficiency 

Puberty problems (early puberty, delayed puberty, excessive hair growth, menstrual irregularity, polycystic ovary syndrome) 

Turner syndrome 

Thyroid diseases (Goiter, hypothyroidism, hyperthyroidism, Hashimoto’s disease, thyroid nodule) 

Sexual development disorders (small penis, undescended testis, gender ambiguity, hypospadias) 

Adrenal gland diseases (Congenital adrenal hyperplasia, Addison’s disease, Cushing’s syndrome) 

Bone and calcium metabolism diseases (rickets, vitamin D deficiency, osteoporosis) 

Education 

Bachelor’s - Master’s: Ankara University Faculty of Medicine (1998-2004) 

Ph.D. - Specialization in Medicine: Child Health and Diseases, Dr. Sami Ulus Gynecology and Childhood Health and Diseases Training and Research Hospital (2005-2010) 

Ph.D. - Minor specialization: Pediatric Endocrinology, Dokuz Eylul University Faculty of Medicine (2010-2013) 

Experience 

Child Health and Diseases Specialist Diyarbakır Children’s Hospital 2010 

Pediatric Endocrine Minor Assistant Dokuz Eylül University Medical Faculty Hospital 2010-2014 

Pediatric Endocrinology Specialist İzmir Tepecik Training and Research Hospital 2014-2015 

Assistant Professor Izmir Katip Celebi University Faculty of Medicine 2015-2016 

Associate Professor Izmir Katip Celebi University Faculty of Medicine 2016-2021 

Pediatric Endocrinology Associate Professor Ulus Liv Hospital 2021- Present 

Pediatric Endocrinology Associate Professor Vadistanbul Liv Hospital 2021- Present

Memberships 

Aegean Child Endocrine and Diabetes Association, Member, 2010 

Pediatric Endocrinology and Diabetes Association, Member, 2010 

Growing Child Association, Member, 2014 

European Society of Pediatric Endocrinology (ESPE), Member, 2016

Professional Summary

Dr. Murat Balanlı is an experienced internal medicine specialist with over 35 years in the field of modern medicine. Since completing his medical education, Dr. Balanlı has continuously expanded his expertise, ultimately embracing a holistic approach to healthcare. Rather than seeing holistic medicine as an alternative, he regards it as an essential extension of conventional treatment that focuses on restoring the unity of mind, body, and spirit. His philosophy, rooted in the idea that medicine is a branch of philosophy, aims to treat not only physical symptoms but also the underlying disruptions to an individual’s overall sense of well-being.

Dr. Balanlı's commitment to lifelong learning, his respect for the arts, and his passion for exploring new perspectives on health have enriched his practice and deepened his connection with patients. His experience includes positions in hospital administration, health institution management, and public health, equipping him with a comprehensive understanding of the healthcare system and patient care at various levels.

*Educational Background

Doctor of Medicine (MD)
Ege University, Faculty of Medicine, 1988

Specialist Training in Internal Medicine
Tepecik Training and Research Hospital, 1994

Master’s Degree in Health Institutions Management
Başkent University, Faculty of Social Sciences, 2012

*Professional Experience

Healthy Living Clinic, Turkey

Founder and Head Practitioner
2014 - Present
Founded and oversees the Healthy Living Clinic, which offers personalized holistic treatment plans to patients. Here, Dr. Balanlı integrates modern medicine with holistic practices, aiming to support patients in achieving both physical health and emotional well-being.

SB Behçet Uz Children's Diseases and Surgery Training and Research Hospital

Hospital Administrator
2015 - 2018
Managed administrative and operational functions at one of Turkey's leading children's hospitals, ensuring high standards of healthcare delivery.

Social Security Institution (SGK), Izmir

Regional Director of Health Affairs
2004 - 2009
Oversaw healthcare services and managed regional health affairs for SGK, contributing to policy-making and service delivery improvements across the region.

Board Member
2009 - 2012
Served on the SGK Board of Directors, actively involved in shaping healthcare policies and advocating for quality, affordable healthcare.

Kayseri Ibn-i Sina Medical Centers

Chief Physician
2003 - 2008
Directed medical services, focusing on the integration of patient-centered care with evidence-based medical practices.

Tokat Niksar State Hospital

Chief Physician
1996
Completed mandatory service as a physician, gaining foundational experience in diverse clinical settings.

*Certifications and Advanced Training

• Neuroanatomy, Neuroelectrophysiology, and Biofeedback
  Completed in Romania
• Biorezonance Medicine and Applications
  Completed in Russia
  Specialized training in biorezonance therapy to support holistic approaches in addressing various chronic and stress-related conditions.

*Key Skills and Expertise

• Internal Medicine
• Holistic Medicine Approaches
• Holistic Wellness Approaches
•  
• Patient-Centered Care
• Biorezonance Therapy
• Health Systems Management
• Hospital and Healthcare Administration

Publications and Contributions

Dr. Balanlı has shared his insights on holistic medicine through articles, presentations, and community health talks, with a focus on bridging modern and holistic approaches. His dedication to sharing knowledge has made him a respected figure in both traditional and holistic medical communities.

Languages

• Turkish (Native)
• English (Fluent)
• Russian (Native)
• Azerbaijani (Fluent)

Prof. Dr. Mustafa ÖZATEŞ

Dr Ozates was born in 1966 in Birecik district of Sanliurfa in Turkey. He completed his primary and secondary education in my hometown, Birecik. He got into Istanbul University Istanbul Faculty of Medicine in 1983. After 6 years of successful education, he started Radiology education at Dicle University Faculty of Medicine by passing the Medical Specialization Examination (TUS) in the same year I graduated in 1989.

Between 1993 and 1995, he worked as a Radiology Specialist in various hospitals in Gaziantep. He passed the Assistant Professorship exam and started to work as a faculty member at Dicle University in 1995.

Post-Specialization Trainings:

2003, Gazi University Faculty of Medicine, MRI Department, Ankara

2003, Marmara University Faculty of Medicine, MRI Department, Istanbul

2001-2004, ESNR European Course of Neuroradiology (3 Semesters)

1997, Johns Hopkins University, Neuroradiology, Baltimore, USA

1997, Cornell University, Neuroradiology, New York, USA

1996, Istanbul University Faculty of Medicine, MRI Department, Istanbul

1994, Dokuz Eylül University Faculty of Medicine, MRI Department, İzmir

1993, Uludağ University Faculty of Medicine, MRI Department, Bursa

1993, UCLA Medical Center (as visitor), Los Angles, USA

1992-1993, Maçka EMAR, Dr. Murat Dinçer, Istanbul

His Academic Studies:

International Publications: 23

International Papers: 27

National Publications: 45

National Papers: 48

Conferences: 11

Citations: 210 Scientific Publications (Average Citations per Item: 10.50, h-index: 9), USA edition 1 Book, Various Conferences

Scientific Organizations he is a member of:

European Society of Radiology (ESR)

Turkish Radiology Association (TRD)

Magnetic Resonance Association

Istanbul Medical Chamber (ITO)

Turkish Neuroradiology Association

In 2003, he was awarded the title of Associate Professor with the examination held at Marmara University Faculty of Medicine. In 2005-2013, Dr. Lütfi Kırdar Kartal Training and Research Hospital Radiology Clinic Chief, Training and Administrative Officer.

In 2013, he started to work as a professor at Nişantaşı University. On March 15, 2013, he was appointed as the Inter-University Board Representative for 1 year. He is a Member of the Board of Trustees of Ayvansaray University. He is a sub – specialist in “Pediatric Radiology”

His articles have been published in many magazines in Turkey and abroad. He presented written and oral presentations and gave conferences at congresses in various cities and countries.

As the Radiology Clinic Chief of Bağcılar Training and Research Hospital, he is the first professor who performed Coronary CT Angiography in a state hospital in Istanbul.

He is one of Turkey’s first Children’s Radiology Specialist Minor. He did his military service between March and April 2000 at the 200-bed Malatya Military Hospital.